Published in J Cell Biol on March 01, 1984
Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe (2010) 2.65
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol (1986) 2.52
Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. EMBO J (1986) 2.38
Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res (2008) 1.96
Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein. J Virol (1990) 1.95
Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol (1987) 1.95
Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J Cell Biol (1986) 1.94
Endocytic pathways in polarized Caco-2 cells: identification of an endosomal compartment accessible from both apical and basolateral surfaces. J Cell Biol (1990) 1.89
Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors. Proc Natl Acad Sci U S A (1985) 1.77
Specific binding of radioiodinated granulocyte-macrophage colony-stimulating factor to hemopoietic cells. EMBO J (1985) 1.63
Saccharomyces cerevisiae mutants unresponsive to alpha-factor pheromone: alpha-factor binding and extragenic suppression. Mol Cell Biol (1987) 1.54
Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol Biol Cell (1995) 1.52
Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor. J Cell Biol (1986) 1.50
Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J Cell Biol (1986) 1.43
Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proc Natl Acad Sci U S A (2010) 1.38
Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane. Proc Natl Acad Sci U S A (2012) 1.32
Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol Cell Biol (1991) 1.32
Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci U S A (1998) 1.29
p180, a novel recycling transmembrane glycoprotein with restricted cell type expression. Mol Cell Biol (1990) 1.28
Rab5 isoforms differentially regulate the trafficking and degradation of epidermal growth factor receptors. J Biol Chem (2009) 1.25
Ligand-mediated internalization, recycling, and downregulation of the epidermal growth factor receptor in vivo. J Cell Biol (1989) 1.21
Direct visualization of the phosphorylated epidermal growth factor receptor during its internalization in A-431 cells. J Cell Biol (1987) 1.19
A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18
Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J (1989) 1.17
The c-SMAC: sorting it all out (or in). J Cell Biol (2005) 1.16
Association of the epidermal growth factor receptor kinase with the detergent-insoluble cytoskeleton of A431 cells. J Cell Biol (1985) 1.14
Recycling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathways. J Cell Biol (1991) 1.12
Annexin VI-mediated loss of spectrin during coated pit budding is coupled to delivery of LDL to lysosomes. J Cell Biol (1998) 1.09
Perinuclear location and recycling of epidermal growth factor receptor kinase: immunofluorescent visualization using antibodies directed to kinase and extracellular domains. J Cell Biol (1986) 1.09
Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells. Exp Cell Res (2008) 1.08
Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis. Proc Natl Acad Sci U S A (1985) 1.06
Characterization of a novel anti-peptide antibody that recognizes a specific conformation of the platelet-derived growth factor receptor. Mol Cell Biol (1988) 1.06
Temperature-dependent tyrosine phosphorylation of microtubule-associated protein kinase in epidermal growth factor-stimulated human fibroblasts. Cell Regul (1991) 1.06
Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses. J Cell Biol (1993) 1.05
Fusion of sequentially internalized vesicles in alveolar macrophages. J Cell Biol (1990) 1.04
Regulation of VEGF signaling by membrane traffic. Cell Signal (2012) 1.04
RNA interference screen identifies Usp18 as a regulator of epidermal growth factor receptor synthesis. Mol Biol Cell (2009) 1.03
Intracellular membrane traffic at high resolution. Methods Cell Biol (2010) 1.00
Epidermal growth factor-nonresponsive 3T3 variants do not contain epidermal growth factor receptor-related antigens or mRNA. Proc Natl Acad Sci U S A (1986) 0.98
Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression. Cell Regul (1990) 0.98
Postendocytic maturation of acid hydrolases: evidence of prelysosomal processing. J Cell Biol (1987) 0.93
Lysosomal accumulation of the hormone-receptor complex during receptor-mediated endocytosis of human choriogonadotropin. J Cell Biol (1984) 0.93
Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7. Oncogene (2010) 0.93
Regulation of fibroblast growth factor receptor signalling and trafficking by Src and Eps8. J Cell Sci (2012) 0.91
Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia. Mol Cell Biol (2012) 0.90
Internalization and degradation of peptides of the bombesin family in Swiss 3T3 cells occurs without ligand-induced receptor down-regulation. EMBO J (1987) 0.88
Oncoprotein stability after tumour resection. Br J Cancer (1990) 0.87
Functional state of the epidermal growth factor-receptor complexes during their internalization in A-431 cells. Mol Cell Biol (1990) 0.82
Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer. Cancer Cell Int (2013) 0.82
Advances in corneal preservation. Trans Am Ophthalmol Soc (1990) 0.80
The murine haemopexin receptor. Evidence that the haemopexin-binding site resides on a 20 kDa subunit and that receptor recycling is regulated by protein kinase C. Biochem J (1991) 0.79
Endocytosis of Fgf8 is a double-stage process and regulates spreading and signaling. PLoS One (2014) 0.78
Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells. Biochem J (1991) 0.76
SPIN90 knockdown attenuates the formation and movement of endosomal vesicles in the early stages of epidermal growth factor receptor endocytosis. PLoS One (2013) 0.75
Activity of the epidermal-growth-factor receptor and phospholipase C-gamma 1 in heat-stressed fibroblasts and A-431 cells. Biochem J (1992) 0.75
Effects of Activating Mutations on EGFR Cellular Protein Turnover and Amino Acid Recycling Determined Using SILAC Mass Spectrometry. Int J Cell Biol (2015) 0.75
Cigarette Smoke Induces Human Epidermal Receptor 2-Dependent Changes in Epithelial Permeability. Am J Respir Cell Mol Biol (2016) 0.75
Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor. Mol Biol Cell (1993) 0.75
17AAG-induced internalisation of HER2-specific Affibody molecules. Oncol Lett (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol (1976) 10.88
Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem (1972) 10.86
A micro biuret method for protein determination; determination of total protein in cerebrospinal fluid. Scand J Clin Lab Invest (1953) 8.04
Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem (1980) 7.71
Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells. Proc Natl Acad Sci U S A (1978) 6.59
Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci U S A (1978) 5.91
Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol (1979) 5.62
The use of intensifying screens or organic scintillators for visualizing radioactive molecules resolved by gel electrophoresis. Methods Enzymol (1980) 5.34
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem (1980) 5.19
Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature (1982) 4.74
Plasma cell immunoglobulin secretion: arrest is accompanied by alterations of the golgi complex. J Exp Med (1977) 4.59
Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor. Proc Natl Acad Sci U S A (1978) 4.31
Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A (1978) 4.03
Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol (1976) 3.91
Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature (1982) 3.90
A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem (1982) 3.81
Hormone receptor topology and dynamics: morphological analysis using ferritin-labeled epidermal growth factor. Proc Natl Acad Sci U S A (1979) 3.54
Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem (1975) 3.48
The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. J Biol Chem (1982) 3.41
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem (1979) 3.18
Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. J Biol Chem (1978) 2.54
Internalization and degradation of macrophage Fc receptors during receptor-mediated phagocytosis. J Cell Biol (1983) 2.49
Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J Biol Chem (1982) 2.10
Epidermal growth factor: biological activity requires persistent occupation of high-affinity cell surface receptors. Proc Natl Acad Sci U S A (1978) 2.02
Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. J Biol Chem (1982) 1.89
Methods for analysis of enzyme synthesis and degradation in animal tissues. Methods Enzymol (1975) 1.39
Thrombin and epidermal growth factor become linked to cell surface receptors during mitogenic stimulation. Nature (1979) 1.23
Production and characterization of antibody blocking epidermal growth factor:receptor interactions. Biochim Biophys Acta (1980) 1.21
Accumulation of epidermal growth factor within cells does not depend on receptor recycling. Biochem Biophys Res Commun (1980) 1.21
Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits. J Biol Chem (1982) 1.20
Characteristics of antibodies to the epidermal growth factor receptor-kinase. Arch Biochem Biophys (1983) 1.16
Proteolytic cleavage of epidermal growth factor receptor. A Ca2+-dependent, sulfhydryl-sensitive proteolytic system in A431 cells. J Biol Chem (1982) 1.15
Direct linkage of epidermal growth factor to its receptor. Nature (1979) 1.11
Cellular location of viral transforming proteins. Cell (1980) 1.01
Calcium facilitates endogenous proteolysis of the EGF receptor-kinase. Mol Cell Endocrinol (1982) 0.88
Regulation of epidermal growth factor (EGF) receptor activity during the modulation of protein synthesis. J Cell Physiol (1979) 0.86
Effect of tunicamycin on the turnover of epidermal growth factor receptors in cultured calf aorta smooth muscle cells. Comparison with IMR-90 human lung fibroblasts. Biochim Biophys Acta (1980) 0.78
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol (1976) 10.88
Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem (1987) 5.57
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J Biol Chem (1980) 5.19
Quantitation of protein. Methods Enzymol (1990) 5.00
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science (2001) 4.90
Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. Science (1990) 4.36
Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol (1976) 3.91
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature (1978) 3.54
Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem (1975) 3.48
Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J Biol Chem (1979) 3.18
Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. Proc Natl Acad Sci U S A (1989) 3.17
Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A (1975) 2.95
All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem (1996) 2.84
Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78
Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells. Science (1988) 2.62
Interaction of activated EGF receptors with coated pit adaptins. Science (1993) 2.42
Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc Natl Acad Sci U S A (1997) 1.90
Acrocephaly, with other Congenital Malformations-Autopsy. Proc R Soc Med (1909) 1.89
Interaction of epidermal growth factor (EGF) with cultured fibroblasts. Adv Metab Disord (1975) 1.88
Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77
Tyrosine residues in bovine phospholipase C-gamma phosphorylated by the epidermal growth factor receptor in vitro. J Biol Chem (1990) 1.75
Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem (1984) 1.62
Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res (1987) 1.61
Tyrosine phosphorylation of phospholipase C-II in vitro by the epidermal growth factor receptor. J Biol Chem (1989) 1.60
Stoichiometric interaction of the epidermal growth factor receptor with the clathrin-associated protein complex AP-2. J Biol Chem (1995) 1.57
Effect of enteral and parenteral feeding in malnourished rats with E. coli-hemoglobin adjuvant peritonitis. J Surg Res (1981) 1.57
Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56
Congenital Morbus cordis-Patent Ductus arteriosus; Aortic Valves Bicuspid; Right Heart dwarfed. Proc R Soc Med (1909) 1.56
Electrophoretic variation in adenylate kinase of Neisseria meningitidis is due to inter- and intraspecies recombination. Proc Natl Acad Sci U S A (1995) 1.48
Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc Natl Acad Sci U S A (1983) 1.48
Enteral and parenteral feeding influences mortality after hemoglobin-E. coli peritonitis in normal rats. J Trauma (1983) 1.47
Identification of two epidermal growth factor-sensitive tyrosine phosphorylation sites of phospholipase C-gamma in intact HSC-1 cells. J Biol Chem (1990) 1.47
Mapping of the molecular determinants involved in the interaction between eps15 and AP-2. Cancer Res (1997) 1.46
Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proc Natl Acad Sci U S A (1999) 1.46
The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene (1993) 1.44
The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem (1999) 1.43
Feedback regulation of phospholipase C-beta by protein kinase C. J Biol Chem (1990) 1.41
Regulation of epidermal growth factor-stimulated formation of inositol phosphates in A-431 cells by calcium and protein kinase C. J Biol Chem (1988) 1.41
Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41
Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41
Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ (1992) 1.41
Vocal cord dysfunction during wartime. Mil Med (1992) 1.39
Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem (1996) 1.36
Epidermal growth factor is a major growth-promoting agent in human milk. Science (1980) 1.35
Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis. J Biol Chem (1991) 1.34
Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry (1980) 1.31
Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor. Science (1990) 1.29
Growth factor stimulation of phospholipase C-gamma 1 activity. Comparative properties of control and activated enzymes. J Biol Chem (1992) 1.28
Letter: Chloramphenicol eye-drops and marrow aplasia. Lancet (1975) 1.27
Epidermal growth factor, its receptor, and related proteins. Exp Cell Res (1986) 1.27
Physiological requirement for both SH2 domains for phospholipase C-gamma1 function and interaction with platelet-derived growth factor receptors. Mol Cell Biol (1999) 1.26
Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene (1998) 1.24
Properties of the receptor for epidermal growth factor. Cell (1984) 1.23
Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23
Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. J Biol Chem (2001) 1.22
Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation. J Biol Chem (2000) 1.22
Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J Biol Chem (1994) 1.22
Production and characterization of antibody blocking epidermal growth factor:receptor interactions. Biochim Biophys Acta (1980) 1.21
Epidermal growth factor (EGF) stimulates inositol trisphosphate formation in cells which overexpress the EGF receptor. Biochem Biophys Res Commun (1987) 1.20
Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol (1997) 1.20
Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem (2000) 1.18
Dimerization of internalized epidermal growth factor receptors. J Biol Chem (1991) 1.18
The biochemistry and physiology of the receptor-kinase for epidermal growth factor. Mol Cell Endocrinol (1983) 1.17
The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene (2006) 1.16
Characteristics of antibodies to the epidermal growth factor receptor-kinase. Arch Biochem Biophys (1983) 1.16
Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol Microbiol (1995) 1.15
Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem (2001) 1.15
Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol (1984) 1.14
Epidermal growth factor receptor: elements of intracellular communication. J Membr Biol (1992) 1.13
The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells. Presence of complex-type N-linked chains that contain terminal N-acetylgalactosamine residues. J Biol Chem (1985) 1.13
EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy. Endocrinology (1985) 1.11
Influence of lectins on the binding of 125I-labeled EGF to human fibroblasts. Biochem Biophys Res Commun (1977) 1.09
SH2 domain-mediated activation of phospholipase Cgamma is not required to initiate Ca2+ release at fertilization of mouse eggs. Dev Biol (1998) 1.08
The regulation of phospholipase C-gamma 1 by phosphatidic acid. Assessment of kinetic parameters. J Biol Chem (1993) 1.08
Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis (2000) 1.06
The regulation of cell proliferation: advances in the biology and mechanism of action of epidermal growth factor. J Invest Dermatol (1978) 1.06
Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins. J Cell Biochem (1986) 1.06
The EGF/TGF alpha receptor in skin. J Invest Dermatol (1990) 1.06
Heregulin degradation in the absence of rapid receptor-mediated internalization. Exp Cell Res (1997) 1.05
Protein assay sensitive at nanogram levels. Anal Biochem (1987) 1.05
Rate constants for binding, dissociation, and internalization of EGF: effect of receptor occupancy and ligand concentration. Biochemistry (1990) 1.04
Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell (1998) 1.04
Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells. J Cell Physiol (1984) 1.04
Interaction of the adaptor protein Shc and the adhesion molecule cadherin. J Biol Chem (1997) 1.03
Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol (1990) 1.01
Solubilization of membrane receptor for epidermal growth factor. Life Sci (1979) 1.01
Phospholipase C-gamma1: regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev (1997) 1.00
Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism. J Cell Physiol (1992) 0.99
Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor. J Biol Chem (1993) 0.99
Binding assays for epidermal growth factor. Methods Enzymol (1985) 0.98
Biology of the A-431 cell: a useful organism for hormone research. J Cell Biochem (1983) 0.98
Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem (1988) 0.98
Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry (1986) 0.97
Selective phospholipase C activation. Bioessays (1991) 0.97